Skip to main content

Table 2 Subgroup analyses of pooled ciprofloxacin resistance in community setting

From: Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies

Subgroup

Community Setting N = 51

P value*

Pooled resistance

Risk of bias

Low and unclear n = 28 studies

0.221

<0.0001

High n = 23 studies

0.337

Study durationa

≤12 months

n = 25 studies

0.323

<0.0001

>12 months

n = 24 studies

0.219

Economy

Developed

n = 16 studies

0.141

<0.0001

Developing

n = 35 studies

0.345

Region

Africa, Asia and Middle East

n = 29 studies

0.361

<0.0001

Europe, North and South America

n = 22 studies

0.174

Age groupa

Adults and children b

n = 24 studies

0.265

<0.0001

Adults only

n = 19 studies

0.302

UTI symptoms

Symptomatic and asymptomatic patients n = 11 studies

0.185

<0.0001

Symptomatic patients only n = 40 studies

0.295

  1. n = number of studies reporting on community acquired UTI
  2. *Comparing pooled resistance for difference in subgroup in community setting
  3. aStudies with missing information on this sub-analysis were not included
  4. bStudies reporting resistance in adults and children or children only